Soichiro Yokota

5.0k total citations
96 papers, 3.4k citations indexed

About

Soichiro Yokota is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, Soichiro Yokota has authored 96 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 45 papers in Oncology and 17 papers in Epidemiology. Recurrent topics in Soichiro Yokota's work include Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (22 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Soichiro Yokota is often cited by papers focused on Lung Cancer Treatments and Mutations (29 papers), Lung Cancer Research Studies (22 papers) and Lung Cancer Diagnosis and Treatment (12 papers). Soichiro Yokota collaborates with scholars based in Japan, United States and United Kingdom. Soichiro Yokota's co-authors include Masahiro Fukuoka, Yutaka Nishiwaki, Masaaki Kawahara, Takahiko Sugiura, Nagahiro Saijo, Koshiro Watanabe, Kazuhiko Nakagawa, Akira Yokoyama, Kazumasa Noda and Minoru Takada and has published in prestigious journals such as Journal of Clinical Oncology, American Journal of Respiratory and Critical Care Medicine and Cancer.

In The Last Decade

Soichiro Yokota

93 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Soichiro Yokota Japan 27 2.0k 1.7k 816 800 267 96 3.4k
Raghunadharao Digumarti India 25 2.4k 1.2× 2.5k 1.5× 602 0.7× 1.1k 1.4× 59 0.2× 150 5.1k
Angela Buonadonna Italy 30 2.8k 1.4× 1.6k 1.0× 355 0.4× 936 1.2× 154 0.6× 142 4.2k
Antonio M. Ballesta Spain 33 985 0.5× 497 0.3× 753 0.9× 984 1.2× 149 0.6× 101 3.4k
Elaine M. Rankin United Kingdom 28 2.1k 1.0× 1.5k 0.9× 802 1.0× 731 0.9× 96 0.4× 60 3.5k
Christine Mateus France 29 3.8k 1.9× 799 0.5× 679 0.8× 1.3k 1.6× 82 0.3× 85 4.9k
Pablo J. Cagnoni United States 25 1.2k 0.6× 830 0.5× 289 0.4× 412 0.5× 53 0.2× 51 2.5k
Jean‐Marie Michot France 37 3.6k 1.8× 937 0.6× 468 0.6× 1.1k 1.4× 91 0.3× 199 5.7k
Siow Ming Lee United Kingdom 38 2.4k 1.2× 2.0k 1.2× 695 0.9× 1.6k 2.0× 43 0.2× 171 4.9k
Jeffrey Crawford United States 38 5.0k 2.5× 2.0k 1.2× 1.1k 1.3× 1.1k 1.4× 44 0.2× 108 6.8k
Nicholas Thatcher United Kingdom 37 3.1k 1.6× 1.5k 0.9× 860 1.1× 1.7k 2.1× 62 0.2× 143 5.1k

Countries citing papers authored by Soichiro Yokota

Since Specialization
Citations

This map shows the geographic impact of Soichiro Yokota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Soichiro Yokota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Soichiro Yokota more than expected).

Fields of papers citing papers by Soichiro Yokota

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Soichiro Yokota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Soichiro Yokota. The network helps show where Soichiro Yokota may publish in the future.

Co-authorship network of co-authors of Soichiro Yokota

This figure shows the co-authorship network connecting the top 25 collaborators of Soichiro Yokota. A scholar is included among the top collaborators of Soichiro Yokota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Soichiro Yokota. Soichiro Yokota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosono, Yuki, Seigo Kitada, Yukihiro Yano, et al.. (2018). The association between erythromycin monotherapy for Mycobacterium avium complex lung disease and cross-resistance to clarithromycin: A retrospective case-series study. Journal of Infection and Chemotherapy. 24(5). 353–357. 7 indexed citations
2.
Stricker, Didier, et al.. (2018). Dense Scene Reconstruction from Spherical Light Fields. 4178–4182. 5 indexed citations
3.
Kanazu, Masaki, Takeshi Uenami, Yukihiro Yano, et al.. (2017). Case series of pleomorphic carcinomas of the lung treated with nivolumab. Thoracic Cancer. 8(6). 724–728. 38 indexed citations
4.
Takayama, Koichi, Shinji Atagi, Fumio Imamura, et al.. (2016). Quality of life and survival survey of cancer cachexia in advanced non-small cell lung cancer patients—Japan nutrition and QOL survey in patients with advanced non-small cell lung cancer study. Supportive Care in Cancer. 24(8). 3473–3480. 74 indexed citations
5.
Hirano, Hiroshi, Hajime Maeda, Yukiyasu Takeuchi, et al.. (2013). Association of cigarette smoking with the expression of nuclear survivin in pathological Stage IA lung adenocarcinomas. Medical Molecular Morphology. 47(4). 196–200. 8 indexed citations
6.
Kijima, Takashi, Masahide Mori, Toshiyuki Minami, et al.. (2012). CXCL12 as a biological marker for the diagnosis of tuberculous pleurisy. Tuberculosis. 92(3). 248–252. 11 indexed citations
7.
8.
Yano, Yukihiro, Yoshinobu Namba, Masahide Mori, et al.. (2012). Treatment of Non-Small-Cell Lung Cancer with Erlotinib following Gefitinib-Induced Hepatotoxicity: Review of 8 Clinical Cases. PubMed. 2012. 1–6. 6 indexed citations
9.
Takahashi, Toshiaki, Nobuyuki Yamamoto, Toshihiro Nukiwa, et al.. (2010). Phase II study of erlotinib in Japanese patients with advanced non-small cell lung cancer.. PubMed. 30(2). 557–63. 30 indexed citations
10.
Mori, Masahide, Takeshi Uenami, Teppei Sugano, et al.. (2010). A case of acute and severe thrombocytopenia due to readministration of rifampicin. Journal of Infection and Chemotherapy. 17(2). 288–290. 9 indexed citations
11.
Mori, Masahide, Hiroyuki Sugahara, Teppei Sugano, et al.. (2010). A case of pulmonary tuberculosis accompanied with immune thrombocytopenic purpura. Respiratory Medicine CME. 3(4). 232–234. 3 indexed citations
12.
Takeda, Koji, Shunichi Negoro, Tomohide Tamura, et al.. (2009). Phase III trial of docetaxel plus gemcitabine versus docetaxel in second-line treatment for non-small-cell lung cancer: results of a Japan Clinical Oncology Group trial (JCOG0104). Annals of Oncology. 20(5). 835–841. 57 indexed citations
13.
Kudoh, Shoji, Harubumi Kato, Yutaka Nishiwaki, et al.. (2008). Interstitial Lung Disease in Japanese Patients with Lung Cancer. American Journal of Respiratory and Critical Care Medicine. 177(12). 1348–1357. 365 indexed citations
14.
Iwasaki, Takeo, Tatsuya Okada, Yoshinobu Namba, et al.. (2005). [A case of lung cancer with cranial neuropathy as the first sign of onset due to metastatic leptomeningeal carcinomatosis].. PubMed. 43(11). 664–7. 1 indexed citations
15.
Hiraga, Toru, Ryoji Maekura, Takashi Okamoto, et al.. (2003). Prognostic predictors for survival in patients with COPD using cardiopulmonary exercise testing. Clinical Physiology and Functional Imaging. 23(6). 324–331. 52 indexed citations
16.
Hanibuchi, Masaki, Toshihiko Yamaguchi, Tatsuya Okada, et al.. (2001). Clinical Examination of Acute Exacerbation of Idiopathic Interstitial Pneumonia (IIP) Combined With Lung Cancer After Anti-cancer Treatment.. Haigan. 41(4). 281–286. 17 indexed citations
17.
Ohno, Masako, Ichiro Yamaguchi, Tomoaki Fukuda, et al.. (2000). Slow N-acetyltransferase 2 genotype affects the incidence of isoniazid and rifampicin-induced hepatotoxicity.. PubMed. 4(3). 256–61. 188 indexed citations
18.
Sugano, M, Nejat K. Egilmez, Soichiro Yokota, et al.. (2000). Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodeficient mice.. PubMed. 60(24). 6942–9. 79 indexed citations
19.
Egilmez, Nejat K., Rosa Cuenca, Soichiro Yokota, F Sorgi, & Richard B. Bankert. (1996). In vivo cytokine gene therapy of human tumor xenografts in SCID mice by liposome-mediated DNA delivery.. PubMed. 3(7). 607–14. 23 indexed citations
20.
Aoki, Masakazu, Toru Katayama, Fumio Yamagishi, et al.. (1994). [Efficacy of PCR-microwell plate hybridization method (Amplicor Mycobacterium) for detection of M. tuberculosis, M. avium and/or M. intracellulare in clinical specimens].. PubMed. 69(10). 593–605. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raghunadharao Digumarti Breakdown of academic impact, for papers by Angela Buonadonna Breakdown of academic impact, for papers by Antonio M. Ballesta Breakdown of academic impact, for papers by Elaine M. Rankin Breakdown of academic impact, for papers by Christine Mateus Breakdown of academic impact, for papers by Pablo J. Cagnoni Breakdown of academic impact, for papers by Jean‐Marie Michot Breakdown of academic impact, for papers by Siow Ming Lee Breakdown of academic impact, for papers by Jeffrey Crawford Breakdown of academic impact, for papers by Nicholas Thatcher
Rankless by CCL
2026